WuXi and Gloria grant Arcus rights to anti-PD-1 antibody; deal worth up to $816mm
WuXi Biologics and partner Harbin Gloria Pharmaceuticals Co. Ltd. granted Arcus Biosciences Inc. exclusive rights to develop and sell the anti-PD-1 antibody GLS010 in North America, Europe, Japan, and other undisclosed territories.
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com